Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Margins on drugs as...

    Margins on drugs as high as 1,192 percent in 4 private hospitals: Indian drug price regulator

    Written by Ruby Khatun Khatun Published On 2018-02-21T12:30:45+05:30  |  Updated On 21 Feb 2018 12:30 PM IST
    Margins on drugs as high as 1,192 percent in 4 private hospitals: Indian drug price regulator

    New Delhi: Non-scheduled drugs and diagnostic services constituted major components of charges billed to patients in four private hospitals with margins as high as 1,192 percent, drug pricing regulator NPPA said.


    For consumables such as a three-way stopcock, BI valve, GS-3040, the margins were even higher. The purchase price of the device for the hospital was Rs 5.77 and a 1,737 per cent margin on procurement price was charged, it added.



    This has emerged from an analysis done by the National Pharmaceutical Pricing Authority (NPPA) after "some unfortunate deaths because of dengue and other ailments in four reputed private hospitals" in Delhi and NCR, the regulator said in a memorandum.








    "Institutional bulk purchases by private hospitals, which in most cases keep a pharmacy of their own, makes it easier for them to get very high-profit margins and indulge in profiteering on drugs and devices even without the need to violate the MRPs, which is already enough inflated," the NPPA said.







    Elaborating on how patients were billed with high margins on medicines, the regulator said in case of Adrenor 2 ml injection with an MRP of Rs 189.95, the purchase price to the hospital was Rs 14.70 but was charged at Rs 5,318.60, inclusive of taxes, to patients.


    The margin on procurement price of the drug used in emergency cases for treatment of potentially life-threatening low blood pressure was 1,192 percent.


    Likewise, the NPPA said Todaycef 1 gm injection was billed to patients at Rs 860, whereas, the purchase price of the hospital was Rs 40.32 although the MRP was Rs 430. The margin on procurement price was 966 percent.


    The drug price regulator did not disclose the names of the four private hospitals.


    The NPPA said the pharmaceuticals industry in order to get bulk supply orders in a way is forced to print higher MRPs as per the market requirements.


    It is amply clear that for claiming higher margins, doctors, hospitals preferred prescribing and dispensing non-scheduled branded medicines instead of scheduled medicines, it said.


    This also indicates that the drug variants of scheduled medicines in the name of new drugs and fixed-dose combinations have become the preferred choice avoid price control by manufacturing and medical fraternity, the regulator said.


    "This trend of migration from scheduled to non-scheduled category is reflected in the growth rate of NLEM and non-NLEM drugs in the year 2017 where the rate of growth of non-NLEM drugs is almost double the rate of NLEM drugs," NPPA said.


    Find the attachment for the same.

    http://www.nppaindia.nic.in/order/overcharging_details(20022018).pdf
    BI valveconsumablesDenguediagnosticdoctorsdrugsGS-3040high marginsmarginsNational Pharmaceutical Pricing AuthorityNLEM drugsnon-NLEM drugsnon-scheduled drugsNPPAprivate hospitalsprivate hospitals delhiprocurement pricepurchase pricethree-way stopcock
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok